PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)

CUSIP: 729139105

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+1,527,488
Put/Call ratio
852%
SEC-reported price per share
$13.17
Number of holders
158
Value change
+$21,507,892
Number of buys
70
Open additional details 1 more signal available
Number of sells
56
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
61,907,011

Security key

729139105

Report period

Q4 2024

Institutions

158

Top holders

10

Ownership snapshot

Top reported holders of PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Third Rock Ventures III, ...
Comparable rows
1/15
Latest evidence
30 Sep 2024
13F 13D/G 3/4/5 Lead comparable stake: 4.8% 14 rows are not safely comparable across share classes. 13D/G row: Redmile Group, LLC Showing 1-6 of 15 holder rows.

Quick read

Redmile Group, LLC leads the comparable SEC ownership view at 4.8%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Redmile Group, LLC's linked filing trail.
Comparable ownership Top 1
Redmile Group, LLC 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Redmile Group, LLC
13F 13D/G
Company
4.8%
Reported 13D/G · 31 Dec 2024
$35,843,874
3,197,491 shares
— 30 Sep 2024
Third Rock Ventures III, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$68,438,025
3,972,027 shares
— 29 Nov 2022
Deep Track Capital, LP
13F
Company
13F
—
denominator unverified
$66,949,001
5,972,257 shares
— 30 Sep 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$58,504,597
5,218,965 shares
— 30 Sep 2024
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$54,200,000
4,834,813 shares
— 30 Sep 2024
FMR LLC
13F
Company
13F
—
denominator unverified
$43,713,185
3,899,481 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
158
Shares
64,754,179
Rows available
158
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
149
Q4 2024 holders
158
Holder diff
9
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .